Immunohistochemical subtypes predict the clinical outcome in high-risk node-negative breast cancer patients treated with adjuvant FEC regimen: results of a single-center retrospective study

BACKGROUND: Anthracycline-based adjuvant chemotherapy improves survival in patients with high-risk node-negative breast cancer (BC). In this setting, prognostic factors predicting for treatment failure might help selecting among the different available cytotoxic combinations. METHODS: Between 1998 a...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahal, S., Boher, J M, Extra, J M, Tarpin, C., Charafe-Jauffret, E., Lambaudie, E., Sabatier, R., Thomassin-Piana, J., Tallet, A., Resbeut, M., Houvenaeghel, G., Laborde, L., Bertucci, F., Viens, P., Gonçalves, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607139/
https://www.ncbi.nlm.nih.gov/pubmed/26466893
http://dx.doi.org/10.1186/s12885-015-1746-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607139/
https://www.ncbi.nlm.nih.gov/pubmed/26466893
http://dx.doi.org/10.1186/s12885-015-1746-3

Ejemplares similares